Literature DB >> 33867561

Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Alex Farr1, Isaak Effendy2, Brigitte Frey Tirri3, Herbert Hof4, Peter Mayser5, Ljubomir Petricevic1, Markus Ruhnke6, Martin Schaller7, Axel P A Schäfer8, Birgit Willinger9, Werner Mendling10.   

Abstract

Aim The aim of this official guideline, published and coordinated by the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Societies of Gynecology and Obstetrics in collaboration with the DMykG, DDG and AGII societies, was to provide consensus-based recommendations obtained by evaluating the relevant literature for the diagnosis, treatment and management of women with vulvovaginal candidosis. Methods This S2k guideline represents the structured consensus of a representative panel of experts with a range of different professional backgrounds commissioned by the Guideline Committee of the above-mentioned societies. Recommendations This guideline gives recommendations for the diagnosis, management, counseling, prophylaxis and screening of vulvovaginal candidosis. Thieme. All rights reserved.

Entities:  

Keywords:  Candida albicans; guideline; pruritus; vulvovaginal candidosis

Year:  2021        PMID： 33867561      PMCID： PMC8046514          DOI： 10.1055/a-1345-8793

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN： 0016-5751            Impact factor:   2.915


  130 in total

1.  Preterm birth reduction after clotrimazole treatment during pregnancy.

Authors:  Andrew E Czeizel; Bernward Fladung; Peter Vargha
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-10-15       Impact factor: 2.435

2.  Prevalence and management of non-albicans vaginal candidiasis.

Authors:  Nalin Hettiarachchi; Nalin Hetticarachchi; H Ruth Ashbee; Janet D Wilson
Journal:  Sex Transm Infect       Date:  2010-04       Impact factor: 3.519

3.  Vaginal yeast colonization in nonpregnant women: a longitudinal study.

Authors:  Richard H Beigi; Leslie A Meyn; Donna M Moore; Marijane A Krohn; Sharon L Hillier
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

4.  Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.

Authors:  Carolina M A Santos; Maria C V Pires; Thiago L Leão; Zulema P Hernández; Marisleydys L Rodriguez; Ariane K S Martins; Lilian S Miranda; Flaviano S Martins; Jacques R Nicoli
Journal:  Microbiology       Date:  2016-05-05       Impact factor: 2.777

5.  Vaginal yeasts in the era of "over the counter" antifungals.

Authors:  P P Walker; M T Reynolds; H R Ashbee; C Brown; E G Evans
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

6.  The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls.

Authors:  Jiri Spacek; Petr Jilek; Vladimir Buchta; Miroslav Forstl; Miloslav Hronek; Magdalena Holeckova
Journal:  Mycoses       Date:  2005-11       Impact factor: 4.377

7.  Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.

Authors:  Ditte Mølgaard-Nielsen; Henrik Svanström; Mads Melbye; Anders Hviid; Björn Pasternak
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

8.  The glyoxylate cycle enzyme activities in the pathogenic isolates of Candida albicans obtained from HIV/AIDS, diabetic and burn patients.

Authors:  Ali Abdul Lattif; Rajendra Prasad; Uma Banerjee; Nivedita Gupta; Sameer Mohammad; Najma Z Baquer
Journal:  Mycoses       Date:  2006-03       Impact factor: 4.377

9.  Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis.

Authors:  G G G Donders; O Babula; G Bellen; I M Linhares; S S Witkin
Journal:  BJOG       Date:  2008-09       Impact factor: 6.531

10.  Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial.

Authors:  Christine L Roberts; Kristen Rickard; George Kotsiou; Jonathan M Morris
Journal:  BMC Pregnancy Childbirth       Date:  2011-03-11       Impact factor: 3.007
View more
  2 in total

1.  Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action.

Authors:  C I S Medeiros; M N A de Sousa; G G A Filho; F O R Freitas; D P L Uchoa; M S C Nobre; A L D Bezerra; L A D M M Rolim; A M B Morais; T B S S Nogueira; R B S S Nogueira; A A O Filho; E O Lima
Journal:  Braz J Med Biol Res       Date:  2022-08-15       Impact factor: 2.904

Review 2.  Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.

Authors:  Gilbert Donders; István Oszkár Sziller; Jorma Paavonen; Phillip Hay; Francesco de Seta; Jean Marc Bohbot; Jan Kotarski; Jordi Antoni Vives; Bela Szabo; Ramona Cepuliené; Werner Mendling
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.